<?xml version="1.0" encoding="UTF-8"?>
<p>Gastrointestinal (GI) cancer is one of the leading causes of death worldwide. It refers to cancers of the upper and lower digestive tracts and mainly includes colorectal adenocarcinoma (CRC), gastric cancer (GC), pancreatic cancer (PC), hepatocellular carcinoma (HCC), and esophageal cancer (EC) (
 <xref rid="B56" ref-type="bibr">Toomey et al., 2013</xref>). Nearly 4.1 million people are diagnosed with GI cancer each year. Epigenetic changes are common events in both initiation and progression of GI cancer (
 <xref rid="B60" ref-type="bibr">Vedeld et al., 2018</xref>). Currently, there are many ways to treat GI cancer. However, most of the treatment outcomes are still poor (
 <xref rid="B4" ref-type="bibr">Bilgin et al., 2017</xref>).
</p>
